Search results for "Informe"

showing 10 items of 186 documents

Moving Toward a Strategy for Addressing Climate Displacement of Marine Resources: A Proof-of-Concept

2020

Realistic predictions of climate change effects on natural resources are central to adaptation policies that try to reduce these impacts. However, most current forecasting approaches do not incorporate species-specific, process-based biological information, which limits their ability to inform actionable strategies. Mechanistic approaches, incorporating quantitative information on functional traits, can potentially predict species- and population-specific responses that result from the cumulative impacts of small-scale processes acting at the organismal level, and can be used to infer population-level dynamics and inform natural resources management. Here we present a proof-of-concept study…

0106 biological sciencesMarine conservationSettore BIO/07 - Ecologia010504 meteorology & atmospheric scienceslcsh:QH1-199.5Engraulis encrasicolusProcess (engineering)Computer scienceClimate changeOcean EngineeringAquatic Sciencelcsh:General. Including nature conservation geographical distributionclimate-informed management; Dynamic Energy Budget model; Engraulis encrasicolus; life-history traits; scenarios; temperature increaseOceanography01 natural sciencesEnvironmental dataDynamic Energy Budget model14. Life underwaterNatural resource managementlcsh:Scienceclimate-informed management0105 earth and related environmental sciencesWater Science and TechnologyGlobal and Planetary Changebusiness.industry010604 marine biology & hydrobiologyEnvironmental resource managementscenariosNatural resourcelife-history traitsAdaptive management13. Climate actionSettore BIO/03 - Botanica Ambientale E Applicatatemperature increaselcsh:QFisheries managementbusiness
researchProduct

Évaluation de l’impact de l’intervention d’un travailleur social auprès d’aidants informels de personnes âgées atteintes d’une pathologie chronique. …

2018

Introduction L’amelioration des conditions de vie et les progres medicaux ont permis un allongement de la duree de vie a des âges tres eleves, lequel a genere l’apparition et le developpement de maladies chroniques associees a des comorbidites. Dans ce contexte, la problematique de la dependance est devenue un enjeu majeur pour les politiques publiques. Depuis de nombreuses annees, elles traduisent leur volonte de faciliter le maintien au domicile le plus longtemps possible a des personnes âgees en perte d’autonomie. Ainsi, cette volonte de continuer a vivre a domicile, directement exprimee par les aines, repose en grande partie sur un reseau d’aides informelles (famille, amis, voisins). Le…

03 medical and health sciencesAidant informelEpidemiologyQualité de vieÉtude randomiséePublic Health Environmental and Occupational Health[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiePersonnes âgée030501 epidemiology0305 other medical scienceCohorte longitudinaleComputingMilieux_MISCELLANEOUSRevue d'Épidémiologie et de Santé Publique
researchProduct

Opportunities and challenges for drug development: public-private partnerships, adaptive designs and big data

2016

Drug development faces the double challenge of increasing costs and increasing pressure on pricing. To avoid that lack of perceived commercial perspective will leave existing medical needs unmet, pharmaceutical companies and many other stakeholders are discussing ways to improve the efficiency of drug Research and Development. Based on an international symposium organized by the Medical School of the University of Duisburg-Essen (Germany) and held in January 2016, we discuss the opportunities and challenges of three specific areas, i.e., public-private partnerships, adaptive designs and big data. Public-private partnerships come in many different forms with regard to scope, duration and typ…

0301 basic medicineLeverage (finance)Big dataMedizinReviewAppropriate useadaptive trial design03 medical and health sciencesDrug DevelopmentInformed consentinvestigator-initiated studiesbig dataPharmacology (medical)RepurposingPharmacologyInformed Consentbusiness.industryManagement sciencelcsh:RM1-950Public relationsEuphemismpublic-private partnershipPublic–private partnership030104 developmental biologylcsh:Therapeutics. PharmacologyDrug developmentPrivacyBusinesspublic–private partnershipFrontiers in Pharmacology
researchProduct

Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients

2016

In the last 20 years, following the identification of the BRCA1 and BRCA2 genes (hereinafter referred to as the BRCA genes), preventive pathways have been developed for the identification and clinical management of individuals at high risk of developing breast and ovarian cancer due to the presence of a pathogenic variant in either of these genes. These pathways are aimed at educating high-risk subjects on programs targeted toward early diagnosis and cancer risk reduction. The approval of a novel class of drugs, the PARP enzyme inhibitors, for the treatment of ovarian cancer patients carrying high-risk BRCA pathogenic variants has changed this scenario. BRCA testing, in addition to providin…

0301 basic medicineOncologyCancer ResearchGenes BRCA2Genes BRCA1Brca testingBRCA1; BRCA2; genetic testing; germline mutations; ovarian cancer; PARP inhibitors; somatic mutations; Oncology; Cancer ResearchSettore MED/03 - GENETICA MEDICA0302 clinical medicineClinical decision makingInformed consentsomatic mutationBRCA1 BRCA2 genetic testing germline mutations somatic mutations ovarian cancer PARP inibitorsDisease management (health)PARP inhibitorsOvarian NeoplasmsTumorInformed Consentmedicine.diagnostic_testDisease ManagementGeneral MedicinePrognosisBRCA1; BRCA2; genetic testing; germline mutations; ovarian cancer; PARP inhibitors; somatic mutations; Biomarkers Tumor; Clinical Decision-Making; Disease Management; Female; Genes BRCA1; Genetic Variation; Germ-Line Mutation; Humans; Informed Consent; Mutation; Ovarian Neoplasms; Prognosis; Genes BRCA2; Genetic Testing; Oncology; Cancer Researchovarian cancergermline mutationOncology030220 oncology & carcinogenesisgermline mutationsFemaleHumanmedicine.medical_specialtyPrognosiClinical Decision-MakingMEDLINEgenetic testing03 medical and health sciencesPARP inibitorsInternal medicinemedicineBiomarkers TumorHumansGerm-Line MutationGenetic testingGynecologyBRCA1; BRCA2; PARP inhibitors; genetic testing; germline mutations; ovarian cancer; somatic mutationsbusiness.industryOvarian NeoplasmGenetic Variationmedicine.diseaseBRCA1BRCA2030104 developmental biologyPARP inhibitorGenesMutationsomatic mutationsOvarian cancerbusinessBiomarkers
researchProduct

Next-generation sequencing in clinical practice: from the patients' preferences to the informed consent process

2016

International audience

0301 basic medicineProcess (engineering)Pilot Projects030105 genetics & heredityNext-generation sequencing NGS03 medical and health sciencesRare Diseasespréférences de spatientsNursingInformed consentHumans[ SHS.ECO ] Humanities and Social Sciences/Economies and financessequençage haut-débitComputingMilieux_MISCELLANEOUSIncidental FindingsInformed ConsentPublic Health Environmental and Occupational HealthHigh-Throughput Nucleotide SequencingPatient PreferenceGeneral Medicineinformed consent processFocus Groups[SHS.ECO]Humanities and Social Sciences/Economics and Financeconsentement informéFocus groupPatient preferenceClinical Practicepatients' preferencesPsychology
researchProduct

Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature

2019

IF 2.004 (2017); International audience; With the development of next generation sequencing, beyond identifying the cause of manifestations that justified prescription of the test, other information with potential interest for patients and their families, defined as secondary findings (SF), can be provided once patients have given informed consent, in particular when therapeutic and preventive options are available. The disclosure of such findings has caused much debate. The aim of this work was to summarize all opinion-based studies focusing on SF, so as to shed light on the concerns that this question generate. A review of the literature was performed, focusing on all PubMed articles repo…

0301 basic medicinemedicine.medical_specialtyPatientsGenetic CounselingDisclosure[SDV.GEN.GH] Life Sciences [q-bio]/Genetics/Human genetics030105 genetics & heredityChoice Behavior03 medical and health sciencesSecondary findingsStakeholder ParticipationInformed consentMultidisciplinary approachExome SequencingGeneticsmedicineHumansGenetic TestingMedical prescriptionExomeGenetics (clinical)Literature reviewIncidental FindingsOpinion based studiesModalitiesStakeholderSubject (documents)General Medicine3. Good healthTest (assessment)030104 developmental biologyAttitude[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human geneticsFamily medicinePsychologyActionabilityEuropean Journal of Medical Genetics
researchProduct

Dissenting voices in a consenting village: lessons from implementation of free, prior and informed consent at a REDD+ pilot in Tanzania

2020

Free, prior and informed consent (FPIC) is a key institutional tool in meeting social safeguards. Its implementation ensures respect of the local people's rights in an intervention. This paper presents a case of FPIC implementation at a REDD+ pilot site. Data were obtained through key informant interviews and focus group discussions with proponents and village members of the Lindi REDD+ project. Findings indicate that the inclusive approach to FPIC by taking the consultations to the hamlet level did not deliver a flawless process. The consent decision was reached by a majority vote, not consensus. There was some dissent, prompting the early establishment of project implementation committees…

040101 forestryEcologybiologyProject implementationmedia_common.quotation_subjectGeography Planning and DevelopmentForestry04 agricultural and veterinary sciencesPublic administrationbiology.organism_classificationFocus groupIntervention (law)Free prior and informed consentTanzaniaDissenting opinionInformed consentPolitical science0401 agriculture forestry and fisheriesDissentmedia_commonInternational Forestry Review
researchProduct

Assessment Capacity, Cultural Validity and Consequential Validity in PISA

2016

La evaluaciones internacionales de estudiantes han desempeñado un papel cada vez más importante en la política educativa. Estas comparaciones internacionales basadas en pruebas generan información valiosa sobre el rendimiento del estudiantado de cada país participante y los factores sociales y contextuales asociados. Una imagen compleja de los factores culturales, económicos y sociales que dan forma a la participación de PISA empieza a emerger. Nuestro objetivo es entender la relación entre la capacidad evaluative nacional y la forma en que los países participan en estas comparaciones internacionales. Proponemos un marco conceptual para examinar la capacidad evaluativa como clave para abord…

060201 languages & linguisticsEducacióneducation05 social sciencesrendimiento comparado050301 educationInforme PISA06 humanities and the artsevaluaciónEducationTest (assessment)validezpolítica de la educación0602 languages and literatureKey (cryptography)Psicología y educación:PEDAGOGÍA [UNESCO]Psychology0503 educationSocial psychologyUNESCO::PEDAGOGÍA
researchProduct

La Muestra Continua de Vidas Laborales (MCVL) como fuente generadora de datos para el estudio del sistema de pensiones

2015

Esta tesis tiene como elemento fundamental de análisis la denominada Muestra Continua de Vidas Laborales (MCVL), como fuente generadora de datos para el estudio del sistema de público de pensiones de España. La MCVL es un conjunto de microdatos individuales anonimizados extraídos de los registros de la Seguridad Social de España. La MCVL se obtiene a partir de un Muestreo Aleatorio Simple (MAS) sobre la población de referencia (conjunto de personas relacionadas durante todo el año con la Seguridad Social, bien como afiliadas o bien como perceptoras de prestaciones, pero con ciertos matices en dicha relación). Los objetivos principales de esta tesis son: - Contribuir a aumentar el conocimien…

:CIENCIAS ECONÓMICAS::Economía sectorial::Finanzas y seguros [UNESCO]UNESCO::MATEMÁTICAS::Investigación operativa::Programación no lineal:MATEMÁTICAS::Probabilidad ::Matemáticas actuariales [UNESCO]Rentas vitaliciasSistema público de pensionesUNESCO::CIENCIAS ECONÓMICAS::Economía sectorial::Finanzas y segurosTest chi-cuadrado:MATEMÁTICAS::Estadística ::Teoría y técnicas de muestreo [UNESCO]Incapacidad permanenteMutuas de Accidentes de TrabajoViudedadCapitalización:MATEMÁTICAS::Investigación operativa::Programación no lineal [UNESCO]Muestreo Aleatorio EstratificadoUNESCO::MATEMÁTICAS::Probabilidad ::Matemáticas actuarialesUNESCO::MATEMÁTICAS::Estadística ::Teoría y técnicas de muestreoInforme Estadístico anual INSSp-valorTamaño del efectoMuestra Continua de Vidas LaboralesSelección de submuestras
researchProduct

Informed consent and medical liability

2018

El reconocimiento del derecho a la información del paciente y del deber de obtener su consentimiento ha supuesto un cambio en el modo de ejercer la medicina. La no obtención del consentimiento informado es causa de responsabilidad profesional, aun a pesar de haber cumplido con el resto de obligaciones médicas y cuidados del paciente. El Tribunal Supremo español considera que la obligación de la información es un elemento esencial de la “lex artis”. Este trabajo analiza esta amplia visión de la jurisprudencia española y los casos en los que la infracción del consentimiento informado da lugar a responsabilidad civil. The recognition of the right of patient’s information and of the duty to obt…

:CIENCIAS JURÍDICAS [UNESCO]Dcho civil y mercantilTort LawDerecho de los pacientesCiencias jurídicasAutonomíaUNESCO::CIENCIAS JURÍDICASResponsabilidad civilDerecho CivilInformed consentConsentimiento informadoAutonomyRights of patients
researchProduct